Malaria Alert Centre, Chichiri, Blantyre, Malawi.
Malar J. 2010 Jul 20;9:209. doi: 10.1186/1475-2875-9-209.
Malaria rapid diagnostics tests (RDTs) can increase availability of laboratory-based diagnosis and improve the overall management of febrile patients in malaria endemic areas. In preparation to scale-up RDTs in health facilities in Malawi, an evaluation of four RDTs to help guide national-level decision-making was conducted.
A cross sectional study of four histidine rich-protein-type-2- (HRP2) based RDTs at four health centres in Blantyre, Malawi, was undertaken to evaluate the sensitivity and specificity of RDTs, assess prescriber adherence to RDT test results and explore operational issues regarding RDT implementation. Three RDTs were evaluated in only one health centre each and one RDT was evaluated in two health centres. Light microscopy in a reference laboratory was used as the gold standard.
A total of 2,576 patients were included in the analysis. All of the RDTs tested had relatively high sensitivity for detecting any parasitaemia [Bioline SD (97%), First response malaria (92%), Paracheck (91%), ICT diagnostics (90%)], but low specificity [Bioline SD (39%), First response malaria (42%), Paracheck (68%), ICT diagnostics (54%)]. Specificity was significantly lower in patients who self-treated with an anti-malarial in the previous two weeks (odds ratio (OR) 0.5; p-value < 0.001), patients 5-15 years old versus patients > 15 years old (OR 0.4, p-value < 0.001) and when the RDT was performed by a community health worker versus a laboratory technician (OR 0.4; p-value < 0.001). Health workers correctly prescribed anti-malarials for patients with positive RDT results, but ignored negative RDT results with 58% of patients with a negative RDT result treated with an anti-malarial.
The results of this evaluation, combined with other published data and global recommendations, have been used to select RDTs for national scale-up. In addition, the study identified some key issues that need to be further delineated: the low field specificity of RDTs, variable RDT performance by different cadres of health workers and the need for a robust quality assurance system. Close monitoring of RDT scale-up will be needed to ensure that RDTs truly improve malaria case management.
疟疾快速诊断检测(RDT)可以增加实验室诊断的可及性,并改善疟疾流行地区发热患者的整体管理。为了在马拉维卫生机构中扩大 RDT 的使用,我们进行了一项评估四种 RDT 的研究,以帮助指导国家层面的决策。
在马拉维布兰太尔的四个卫生中心进行了四项基于组氨酸丰富蛋白 2(HRP2)的 RDT 的横断面研究,以评估 RDT 的敏感性和特异性,评估医生对 RDT 检测结果的依从性,并探讨 RDT 实施的操作问题。三种 RDT 仅在一个卫生中心进行了评估,一种 RDT 在两个卫生中心进行了评估。参考实验室的显微镜检查被用作金标准。
共有 2576 名患者纳入分析。所有测试的 RDT 对检测任何寄生虫血症的敏感性都相对较高[Bioline SD(97%)、First response malaria(92%)、Paracheck(91%)、ICT diagnostics(90%)],但特异性较低[Bioline SD(39%)、First response malaria(42%)、Paracheck(68%)、ICT diagnostics(54%)]。在过去两周内自行用抗疟药治疗的患者(比值比(OR)0.5;p 值<0.001)、5-15 岁患者与>15 岁患者(OR 0.4,p 值<0.001)以及 RDT 由社区卫生工作者而不是实验室技术员进行时(OR 0.4;p 值<0.001),特异性显著降低。卫生工作者正确地为 RDT 阳性结果的患者开具了抗疟药,但忽略了 RDT 阴性结果,58%的 RDT 阴性结果患者接受了抗疟药治疗。
本评估的结果,结合其他已发表的数据和全球建议,已被用于选择 RDT 进行国家层面的推广。此外,该研究还确定了一些需要进一步阐明的关键问题:RDT 的现场特异性较低、不同卫生工作者群体的 RDT 性能差异以及对稳健的质量保证体系的需求。需要密切监测 RDT 的推广情况,以确保 RDT 真正改善疟疾病例管理。